K Pharma,Inc. Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	10,112	7,659	7,206	8,355	-	-
Market Cap Growth	28.90%	6.28%	-13.75%	-	-	-
Enterprise Value	8,821	6,155	4,691	6,443	-	-
Last Close Price	871.00	660.00	621.00	720.00	-	-
PE Ratio	-	-	-	32.14	-	-
PS Ratio	-	-	-	8.36	-	-
PB Ratio	7.99	6.06	3.19	2.69	-	-
P/TBV Ratio	7.99	6.06	3.19	2.69	-	-
P/FCF Ratio	-	-	-	18.78	-	-
P/OCF Ratio	-	-	-	18.40	-	-
EV/Sales Ratio	-	-	-	6.44	-	-
EV/EBIT Ratio	-	-	-	17.56	-	-
EV/FCF Ratio	-9.50	-	-	14.48	-	-
Debt / Equity Ratio	1.19	1.19	-	-	-	-
Net Debt / Equity Ratio	-1.02	-1.02	-1.00	-1.05	-1.00	-1.06
Net Debt / FCF Ratio	1.39	1.39	2.28	-7.34	-	-
Asset Turnover	-	-	-	0.43	-	-
Inventory Turnover	-	-	-	9.00	-	-
Quick Ratio	27.63	27.63	36.00	18.35	40.49	8.17
Current Ratio	28.61	28.61	37.27	18.58	41.52	8.87
Return on Equity (ROE)	-56.37%	-56.37%	-31.55%	11.71%	-51.78%	-
Return on Assets (ROA)	-21.64%	-21.64%	-18.44%	9.79%	-27.94%	-
Return on Invested Capital (ROIC)	-118.50%	-125.14%	-	-	-	-
Return on Capital Employed (ROCE)	-32.30%	-32.30%	-36.50%	11.70%	-26.30%	-120.30%
Earnings Yield	-9.82%	-12.96%	-11.74%	3.11%	-	-
FCF Yield	-9.19%	-12.13%	-13.84%	5.33%	-	-
Buyback Yield / Dilution	-0.00%	-0.00%	-2.97%	-20.79%	-22.75%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.